Home » Healthcare » South Africa Gastrointestinal Products Market

South Africa Gastrointestinal Products Market By Devices (Endoscopy Devices, Ablation Devices, Motility Testing Devices, Biopsy Devices, Stenting Devices); By Indications (Gastrointestinal Cancers, Gastroesophageal Reflux Disease, Irritable Bowel Syndrome, Inflammatory Bowel Disease, Other Diseases); By End-User (Hospitals, Ambulatory Surgical Centers & Independent Surgical Centers, Clinics, Other End Users) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2019-2022
Base Year	2023
Forecast Period	2024-2032
South Africa Gastrointestinal Products Market Size 2023	USD 57.82 million
South Africa Gastrointestinal Products Market, CAGR	3.13%
South Africa Gastrointestinal Products Market Size 2032	USD 76.74 million

Market Overview

The South Africa Gastrointestinal Products Market is projected to grow from USD 57.82 million in 2023 to USD 76.74 million by 2032, with a compound annual growth rate (CAGR) of 3.13%.

The South Africa gastrointestinal products market is driven by increasing prevalence of gastrointestinal disorders, growing awareness about digestive health, and advancements in treatment options. Rising adoption of healthier lifestyles, coupled with improved access to healthcare services, is propelling market growth. Additionally, the demand for over-the-counter (OTC) products and prescription medications is rising, as consumers seek more convenient and effective solutions for managing digestive issues. Trends include the increasing popularity of natural and herbal-based gastrointestinal products, as well as the growing role of telemedicine and digital health tools for diagnosis and treatment. Furthermore, the expansion of product offerings by key players and continuous innovations in formulations are contributing to the market’s growth. As the South African population becomes more health-conscious, the demand for gastrointestinal products is expected to continue its upward trajectory, supported by favorable regulatory developments and a rise in healthcare expenditure.

The South African gastrointestinal products market is driven by key regions such as Gauteng, Western Cape, KwaZulu-Natal, and Eastern Cape, each contributing to the growing demand for gastrointestinal treatments. The market benefits from well-developed healthcare infrastructure in urban areas, especially in Gauteng and Western Cape, which support the adoption of advanced gastrointestinal products. Key players in the market include global and local companies such as Olympus, Boston Scientific, Fujifilm, and Medtronic, which provide a wide range of diagnostic devices and therapeutic solutions. These companies are strengthening their presence in South Africa by expanding their product portfolios and focusing on innovative solutions for gastrointestinal disorders. With increasing awareness and advancements in healthcare delivery, these companies are poised to cater to the growing needs of South African consumers, including both urban and rural populations, and drive the market’s growth across the region.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Market Insights

The South African gastrointestinal products market was valued at USD 57.82 million in 2023 and is expected to reach USD 76.74 million by 2032, growing at a CAGR of 3.13%.
Increasing prevalence of gastrointestinal disorders like IBS and GERD is driving the demand for related treatments and diagnostic devices.
Growing consumer awareness about digestive health is fueling demand for preventive care products, including probiotics and supplements.
The market is witnessing a shift toward natural and herbal gastrointestinal solutions, as consumers opt for plant-based treatments.
Competitive pressure from local and global players, such as Olympus, Boston Scientific, and Medtronic, is leading to innovations in product offerings.
Regulatory challenges and the high cost of advanced treatment options remain significant barriers to market growth.
Urban regions like Gauteng and Western Cape dominate the market, but increasing healthcare access in rural areas offers growth opportunities.

Market Drivers

Rising Prevalence of Gastrointestinal Disorders

The increasing incidence of gastrointestinal (GI) disorders in South Africa is a key driver for the market growth. Conditions such as irritable bowel syndrome (IBS), acid reflux, and inflammatory bowel diseases (IBD) are becoming more common, prompting a higher demand for treatment solutions. For instance, a study by the South African Medical Research Council highlighted a significant rise in the prevalence of IBS and GERD among urban populations. A growing number of individuals seeking effective treatments for chronic digestive issues is fueling the need for gastrointestinal products, including medications, supplements, and dietary interventions.

Growing Awareness of Digestive Health

As public awareness about digestive health continues to rise, consumers are becoming more proactive in seeking solutions to prevent and manage GI issues. Increased knowledge of the link between diet, lifestyle, and gastrointestinal health is prompting individuals to turn to products designed to improve digestion, gut health, and overall well-being. For instance, the South African Health and Nutrition Examination Survey (SANHANES) has been instrumental in raising public awareness about the importance of digestive health. The widespread availability of information through digital platforms, health seminars, and educational campaigns is encouraging people to address digestive concerns more promptly.

Shift Toward Natural and Herbal Products

A significant market trend in South Africa is the growing preference for natural and herbal gastrointestinal products. Consumers are increasingly seeking alternatives to pharmaceutical treatments, opting for plant-based remedies, probiotics, and dietary supplements. The demand for organic, gluten-free, and non-GMO products is rising, as people become more conscious of the ingredients and additives in their food and medications. This shift is driving the introduction of innovative natural-based products by market players.

Improved Healthcare Access and Infrastructure

Enhanced access to healthcare and improved infrastructure in South Africa are facilitating the growth of the gastrointestinal products market. With better healthcare facilities, more people are able to seek timely medical advice, receive accurate diagnoses, and gain access to a variety of gastrointestinal treatments. Furthermore, the rise of telemedicine and online consultations is making it easier for patients to obtain prescriptions and advice, driving the consumption of gastrointestinal products. Increased government investments in healthcare infrastructure are also contributing to market expansion.

Market Trends

Increasing Demand for OTC Products

One of the key trends in the South African gastrointestinal products market is the growing preference for over-the-counter (OTC) products. As consumers become more health-conscious and seek convenient solutions for managing digestive issues, the demand for OTC medications such as antacids, laxatives, and probiotics is rising. These products provide easy accessibility without the need for prescriptions, appealing to individuals who prefer self-treatment options. For instance, the South African OTC pharmaceuticals market has seen a significant increase in demand for digestive health products, reflecting a broader shift toward personalized, on-demand healthcare solutions. The trend reflects a broader shift toward personalized, on-demand healthcare solutions, especially among the younger, tech-savvy population.

Advancements in Product Formulations

Advancements in the formulation of gastrointestinal products are another prominent market trend. Manufacturers are increasingly focusing on developing products with enhanced effectiveness and fewer side effects. Innovations such as multi-action probiotics, targeted enzyme supplements, and specialized fiber-based treatments are gaining popularity. Additionally, the development of personalized formulations based on genetic and microbiome insights is expected to further boost product offerings. These innovations are driving growth as consumers seek more tailored and efficient solutions to address their specific digestive health concerns.

Rising Popularity of Digital Health Solutions

The integration of digital health technologies in gastrointestinal care is a growing trend in South Africa. Telemedicine and digital platforms are playing an important role in diagnosing and managing digestive disorders. Many healthcare providers are now offering virtual consultations and using mobile apps to track symptoms, monitor treatment progress, and recommend appropriate products. This trend not only improves access to care but also facilitates the timely use of gastrointestinal products, especially in remote areas where healthcare facilities may be limited. The adoption of digital health tools is expected to continue expanding as technology becomes more integrated into everyday healthcare.

Focus on Preventive Care and Lifestyle Adjustments

There is a noticeable trend toward preventive care and lifestyle changes as part of digestive health management in South Africa. Consumers are increasingly prioritizing diet, exercise, and stress management to prevent gastrointestinal issues before they arise. As a result, the demand for products that promote gut health, such as prebiotics, fiber supplements, and digestive enzymes, is on the rise. This trend reflects a broader societal shift toward proactive health management, with individuals actively seeking solutions that support long-term digestive well-being rather than just addressing symptoms.

Market Challenges Analysis

Regulatory and Compliance Issues

One of the major challenges facing the South Africa gastrointestinal products market is navigating regulatory and compliance hurdles. The pharmaceutical and dietary supplement sectors are highly regulated, with strict requirements for product approval, labeling, and marketing. Companies must ensure that their products meet the standards set by regulatory bodies like the South African Health Products Regulatory Authority (SAHPRA). For instance, the approval process for new gastrointestinal products can be time-consuming and expensive, often taking several months to years to complete. The process of obtaining approval for new gastrointestinal products can be time-consuming and expensive, posing a challenge, particularly for smaller companies. Moreover, ongoing regulatory changes and updates to safety standards may create uncertainty, making it difficult for manufacturers to stay compliant and plan for long-term market strategies.

Market Competition and Pricing Pressure

The South African gastrointestinal products market is highly competitive, with both international and local players vying for market share. This intense competition leads to pricing pressure, as companies are forced to lower their prices to remain attractive to price-sensitive consumers. While the demand for gastrointestinal products is growing, economic challenges in South Africa, such as high unemployment rates and inflation, make affordability a concern for many individuals. Consumers are increasingly seeking cost-effective alternatives, which creates a challenge for companies to maintain profitability while catering to this demand. Additionally, the rise of generic and unbranded products further intensifies competition, as these often come at lower prices, posing additional pressure on branded products to differentiate themselves in the market.

Market Opportunities

Expanding Consumer Awareness and Health Trends

A significant opportunity in the South African gastrointestinal products market lies in the growing consumer awareness of digestive health and its importance to overall well-being. As more individuals become proactive in managing their health, there is a rising demand for products that support digestive function, including probiotics, fiber supplements, and natural remedies. This trend aligns with the increasing interest in preventive healthcare, where consumers are focused on maintaining digestive health rather than only addressing symptoms. The opportunity for manufacturers lies in targeting this health-conscious demographic by offering products that cater to their specific needs, such as gut health-promoting supplements and dietary products. Additionally, educating consumers on the long-term benefits of maintaining good digestive health can further boost demand for such products.

Technological Advancements and Digital Integration

Technological advancements in both product development and healthcare delivery present significant opportunities in the South African gastrointestinal products market. The rise of digital health platforms and telemedicine offers companies the chance to integrate their products into virtual healthcare services, expanding their reach and accessibility. With the growing use of mobile apps for health monitoring, companies can leverage these platforms to offer personalized solutions based on individual health data, creating a more tailored consumer experience. Furthermore, innovations in product formulations, such as personalized probiotics and targeted treatments, offer an opportunity to capture a larger share of the market by providing effective, customized solutions for digestive issues. These advancements, combined with an increasing preference for natural and plant-based treatments, provide multiple avenues for growth and differentiation in a competitive market.

Market Segmentation Analysis:

By Devices:

The South Africa gastrointestinal products market is segmented by devices into endoscopy devices, ablation devices, motility testing devices, biopsy devices, and stenting devices. Endoscopy devices dominate this segment, driven by their widespread use for diagnosing and treating various gastrointestinal disorders, including cancers and reflux diseases. Ablation devices are gaining popularity, especially in the treatment of GI cancers, as they offer minimally invasive treatment options. Motility testing devices, which assess gastrointestinal function, are becoming essential tools for diagnosing motility disorders like IBS. Biopsy devices are crucial for diagnosing cancers and other GI diseases, making them indispensable in clinical settings. Stenting devices are also in demand, especially for treating esophageal conditions and blockages in the gastrointestinal tract. As the market for GI devices grows, technological advancements and increasing healthcare access contribute to the increasing adoption of these devices in South Africa.

By Indications:
In terms of indications, the South African gastrointestinal products market is segmented into gastrointestinal cancers, gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), and other diseases. Gastrointestinal cancers are a significant driver of market growth, particularly with increasing awareness and advancements in diagnostic and therapeutic products. GERD remains a common indication, prompting demand for both devices and pharmaceutical products aimed at symptom relief. IBS and IBD are also key segments, with rising prevalence leading to a greater need for effective treatments. Products catering to these diseases, including medications, supplements, and diagnostic devices, are experiencing robust growth. The “other diseases” segment includes a variety of gastrointestinal disorders, further broadening the scope for product development and market expansion. As the demand for targeted treatments increases, the market for gastrointestinal products in South Africa is expected to continue evolving to meet diverse consumer needs.

Segments:

Based on Devices:

Endoscopy Devices
Ablation Devices
Motility Testing Devices
Biopsy Devices
Stenting Devices

Based on Indications:

Gastrointestinal Cancers
Gastroesophageal Reflux Disease
Irritable Bowel Syndrome
Inflammatory Bowel Disease
Other Diseases

Based on End-User:

Hospitals
Ambulatory Surgical Centers & Independent Surgical Centers
Clinics
Other End Users

Based on the Geography:

Gauteng
Western Cape
KwaZulu-Natal
Eastern Cape

Regional Analysis

Gauteng

Gauteng holds the largest market share, accounting for approximately 40% of the total market. This dominance is driven by Gauteng’s high population density, urbanization, and well-developed healthcare infrastructure, making it a hub for healthcare services and medical product distribution. The region’s extensive healthcare network, combined with a rising awareness of gastrointestinal health, fuels the demand for a wide range of gastrointestinal products, from pharmaceuticals to diagnostic devices. The growing number of hospitals, clinics, and specialty centers in Gauteng further bolsters market penetration and accessibility to these products.

Western Cape Market Share

Western Cape is another key player in the South African gastrointestinal products market, holding around 25% of the market share. The region benefits from its strong healthcare infrastructure and a growing population of health-conscious individuals, particularly in urban areas like Cape Town. The increasing prevalence of gastrointestinal disorders in Western Cape has led to a rising demand for both over-the-counter products and advanced medical devices. Additionally, the region’s increasing adoption of digital health tools and telemedicine contributes to the accessibility of gastrointestinal products, further fueling market growth. Western Cape also sees a shift toward preventive healthcare, with consumers actively seeking products to maintain digestive health, thereby enhancing the market’s expansion in the region.

KwaZulu-Natal Market Share

KwaZulu-Natal holds a market share of approximately 20% in the South African gastrointestinal products market. The region’s demand for gastrointestinal products is driven by both urban and rural populations, with a growing need for effective treatment options for conditions like gastroesophageal reflux disease (GERD), irritable bowel syndrome (IBS), and inflammatory bowel disease (IBD). Healthcare access in urban centers such as Durban is relatively high, leading to increased consumption of both pharmaceuticals and medical devices. However, challenges remain in rural areas, where there is a need for improved healthcare infrastructure and access to gastrointestinal treatments. As the government continues to invest in healthcare facilities in KwaZulu-Natal, the market is expected to experience steady growth, with increasing awareness of digestive health contributing to the demand for a diverse range of products.

Eastern Cape Market Share

The Eastern Cape represents around 15% of the South African gastrointestinal products market. Although the region has a smaller market share compared to Gauteng and Western Cape, it is experiencing significant growth due to improvements in healthcare accessibility and rising awareness of gastrointestinal health. Eastern Cape has a large rural population, which poses challenges in terms of product distribution and healthcare access. However, urban centers like Port Elizabeth and East London are witnessing growing demand for gastrointestinal products. As healthcare infrastructure improves and local residents gain greater awareness of gastrointestinal conditions, the market for these products is poised for expansion. Efforts to enhance distribution networks and raise awareness about digestive health will contribute to further growth in the Eastern Cape.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Olympus
Boston Scientific
Fujifilm
Ethicon Endo-Surgery
Medtronic
Stryker
Smith & Nephew
Karl Storz
Hoya
Company 10
Company 11
Company 12
Company 13
Company 14

Competitive Analysis

The competitive landscape of the South African gastrointestinal products market is marked by the presence of both global and local companies that provide a diverse range of diagnostic and therapeutic solutions. Leading players in the market include Olympus, Boston Scientific, Fujifilm, Ethicon Endo-Surgery, Medtronic, Stryker, Smith & Nephew, Karl Storz, and Hoya. Companies compete primarily on product innovation, quality, and their ability to meet the growing demand for advanced gastrointestinal treatments. A key area of competition is the development of minimally invasive technologies, which have become increasingly popular due to their ability to reduce recovery times and improve patient outcomes. For instance, Boston Scientific has partnered with several leading hospitals to enhance the adoption of their advanced gastrointestinal devices. Additionally, firms focus on expanding their product portfolios to include cutting-edge devices for endoscopy, biopsy, and motility testing, while also addressing the demand for pharmaceuticals and supplements. To gain a competitive edge, players are also focusing on enhancing customer service and establishing strong distribution networks to ensure that their products reach healthcare providers efficiently. Another strategy is to invest heavily in research and development to create more effective and user-friendly devices, which are particularly important for treating chronic conditions like GERD, IBS, and gastrointestinal cancers. Furthermore, as the market becomes more price-sensitive, offering cost-effective solutions without compromising on quality has become a critical factor for success. Companies also work to strengthen relationships with hospitals, clinics, and physicians to improve product adoption and gain a competitive advantage in the region.

Recent Developments

In April 2023, Boston Scientific announced the launch of the EXALT Model B Single-use Bronchoscope, which expands its single-use endoscopy portfolio. This device is designed for diagnostic and therapeutic bronchoscopy procedures and offers high-resolution imaging and precise control.
In March 2023, Polifarma Spa expanded its gastrointestinal portfolio through a long-term distribution agreement with Devintec Pharma Sagl, a Lugano-based company known for pioneering substance-based medical devices and the Gelsectan brand.
In April 2023, Italian pharmaceutical innovator Azienda Farmaceutica Italiana partnered with TannerLAC, Inc. to distribute Hepilor, a medical device designed to protect the digestive system mucosa, throughout Latin America.
In May 2022, Dr. Reddy’s Laboratories Ltd. announced a partnership with South Korea’s HK inno.N Corporation to supply and commercialize HK inno.N’s patented novel molecule, Tegoprazan, for treating gastrointestinal diseases in India and six key emerging markets.
In March 2022, AbbVie Inc. received U.S. FDA approval for its novel drug, RINVOQ (upadacitinib), for the treatment of moderately to severely active ulcerative colitis.

Market Concentration & Characteristics

The South African gastrointestinal products market exhibits moderate concentration, with a mix of dominant global players and emerging local companies. While the market is led by established international brands offering a broad range of diagnostic and therapeutic solutions, local companies are gaining ground by providing more affordable, tailored alternatives. The presence of both large multinational corporations and smaller, more agile players creates a competitive landscape where innovation, pricing, and customer relationships are key drivers. Market characteristics are shaped by an increasing demand for advanced gastrointestinal treatments, driven by the rising prevalence of gastrointestinal disorders such as GERD, IBS, and IBD. As a result, the focus has shifted towards the development of minimally invasive technologies, including endoscopic devices and diagnostic tools. Companies are also capitalizing on the growing consumer awareness of digestive health by offering products that support preventive care, such as probiotics and dietary supplements. Additionally, the market is characterized by significant regulatory scrutiny, which ensures that only safe and effective products are introduced. The overall market is influenced by trends in healthcare accessibility, with urban regions like Gauteng and Western Cape experiencing higher adoption rates due to better healthcare infrastructure. As demand continues to rise, the market is expected to grow steadily, offering opportunities for both established and new players.

Report Coverage

The research report offers an in-depth analysis based on Devices, Indications, End-User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The South African gastrointestinal products market is expected to grow steadily due to increasing prevalence of gastrointestinal disorders.
Technological advancements in minimally invasive treatments will drive demand for new diagnostic and therapeutic devices.
The rising consumer awareness of digestive health will lead to increased adoption of preventive care products like probiotics and supplements.
Growth in healthcare infrastructure and access, especially in rural areas, will expand the market reach.
Rising healthcare costs may push consumers to seek more affordable yet effective gastrointestinal solutions.
The demand for personalized medicine, including targeted therapies for gastrointestinal conditions, will increase.
Collaboration between global and local companies will strengthen the availability of advanced gastrointestinal products in the region.
Regulatory compliance and product safety will continue to play a crucial role in market dynamics.
The market will see a shift towards digital health solutions, such as mobile apps for digestive health monitoring.
Ongoing research and development will introduce innovative products, further driving competition and market expansion.

CHAPTER NO. 1 : INTRODUCTION 20

1.1.1. Report Description 20

Purpose of the Report 20

USP & Key Offerings 20

1.1.2. Key Benefits for Stakeholders 20

1.1.3. Target Audience 21

1.1.4. Report Scope 21

CHAPTER NO. 2 : EXECUTIVE SUMMARY 22

2.1. GASTROINTESTINAL PRODUCTS Market Snapshot 22

2.1.1. South Africa GASTROINTESTINAL PRODUCTS Market, 2018 – 2032 (USD Million) 23

CHAPTER NO. 3 : GEOPOLITICAL CRISIS IMPACT ANALYSIS 24

3.1. Russia-Ukraine and Israel-Palestine War Impacts 24

CHAPTER NO. 4 : GASTROINTESTINAL PRODUCTS MARKET – INDUSTRY ANALYSIS 25

4.1. Introduction 25

4.2. Market Drivers 26

4.2.1. GI Disorders on a Rise 26

4.2.2. New and innovative technologies driving the market 27

4.3. Market Restraints 28

4.3.1. Stringent Regulations 28

4.4. Market Opportunities 29

4.4.1. Market Opportunity Analysis 29

4.5. Porter’s Five Forces Analysis 30

4.6. Value Chain Analysis 31

4.7. Buying Criteria 32

CHAPTER NO. 5 : IMPORT EXPORT ANALYSIS 33

5.1. Import Analysis by South Africa 33

5.1.1. South Africa GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By South Africa, 2018 – 2023 33

5.2. Export Analysis by South Africa 34

5.2.1. South Africa GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By South Africa, 2018 – 2023 34

CHAPTER NO. 6 : DEMAND SUPPLY ANALYSIS 35

6.1. Demand Analysis by South Africa 35

6.1.1. South Africa GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By South Africa, 2018 – 2023 35

6.2. Supply Analysis by South Africa 36

6.2.1. South Africa GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By South Africa, 2018 – 2023 36

CHAPTER NO. 7 : PRODUCTION ANALYSIS 37

7.1. Production Analysis by South Africa 37

7.1.1. South Africa GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By South Africa, 2018 – 2023 37

CHAPTER NO. 8 : PRICE ANALYSIS 38

8.1. Price Analysis by Devices 38

8.1.1. South Africa GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 38

8.1.2. South Africa Devices Market Price, By Devices, 2018 – 2023 38

CHAPTER NO. 9 : RAW MATERIALS ANALYSIS 39

9.1. Key Raw Materials and Suppliers 39

9.2. Key Raw Materials Price Trend 39

CHAPTER NO. 10 : MANUFACTURING COST ANALYSIS 40

10.1. Manufacturing Cost Analysis 40

10.2. Manufacturing Process 40

CHAPTER NO. 11 : ANALYSIS COMPETITIVE LANDSCAPE 41

11.1. Company Market Share Analysis – 2023 41

11.1.1. South Africa GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Volume, 2023 41

11.1.2. South Africa GASTROINTESTINAL PRODUCTS Market: Company Market Share, by Revenue, 2023 42

11.1.3. South Africa GASTROINTESTINAL PRODUCTS Market: Top 6 Company Market Share, by Revenue, 2023 42

11.1.4. South Africa GASTROINTESTINAL PRODUCTS Market: Top 3 Company Market Share, by Revenue, 2023 43

11.2. South Africa GASTROINTESTINAL PRODUCTS Market Company Volume Market Share, 2023 44

11.3. South Africa GASTROINTESTINAL PRODUCTS Market Company Revenue Market Share, 2023 45

11.4. Company Assessment Metrics, 2023 46

11.4.1. Stars 46

11.4.2. Emerging Leaders 46

11.4.3. Pervasive Players 46

11.4.4. Participants 46

11.5. Start-ups /SMEs Assessment Metrics, 2023 46

11.5.1. Progressive Companies 46

11.5.2. Responsive Companies 46

11.5.3. Dynamic Companies 46

11.5.4. Starting Blocks 46

11.6. Strategic Developments 47

11.6.1. Acquisitions & Mergers 47

New Product Launch 47

South Africa Expansion 47

11.7. Key Players Product Matrix 48

CHAPTER NO. 12 : PESTEL & ADJACENT MARKET ANALYSIS 49

12.1. PESTEL 49

12.1.1. Political Factors 49

12.1.2. Economic Factors 49

12.1.3. Social Factors 49

12.1.4. Technological Factors 49

12.1.5. Environmental Factors 49

12.1.6. Legal Factors 49

12.2. Adjacent Market Analysis 49

CHAPTER NO. 13 : GASTROINTESTINAL PRODUCTS MARKET – BY DEVICES SEGMENT ANALYSIS 50

13.1. GASTROINTESTINAL PRODUCTS Market Overview, by Devices Segment 50

13.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 51

13.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Devices 52

13.1.3. Incremental Revenue Growth Opportunity, by Devices, 2024 – 2032 52

13.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 53

13.2. Endoscopy Devices 54

13.3. Ablation Devices 55

13.4. Motility Testing Devices 56

13.5. Biospy Devices 57

13.6. Stenting Devices 58

CHAPTER NO. 14 : GASTROINTESTINAL PRODUCTS MARKET – BY INDICATIONS SEGMENT ANALYSIS 59

14.1. GASTROINTESTINAL PRODUCTS Market Overview, by Indications Segment 59

14.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 60

14.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By Indications 61

14.1.3. Incremental Revenue Growth Opportunity, by Indications, 2024 – 2032 61

14.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 62

14.2. Gastrointestinal Cancers 63

14.3. Gastroesophageal Reflux Disease 64

14.4. Irritable Bowl Syndrome 65

14.5. Inflammatory Bowel Disease 66

14.6. Other Disease 67

CHAPTER NO. 15 : GASTROINTESTINAL PRODUCTS MARKET – BY END-USER SEGMENT ANALYSIS 68

15.1. GASTROINTESTINAL PRODUCTS Market Overview, by End-user Segment 68

15.1.1. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 69

15.1.2. GASTROINTESTINAL PRODUCTS Market Attractiveness Analysis, By End-user 70

15.1.3. Incremental Revenue Growth Opportunity, by End-user, 2024 – 2032 70

15.1.4. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 71

15.2. Hospital 72

15.3. Ambulatory Surgical Center & Independent Surgical Center 73

15.4. Clinics 74

15.5. Other End Users 75

CHAPTER NO. 16 : COMPANY PROFILES 76

16.1. Olympus 76

16.1.1. Company Overview 76

16.1.2. Product Portfolio 76

16.1.3. Swot Analysis 76

16.1.4. Business Strategy 77

16.1.5. Financial Overview 77

16.2. Boston Scientific 78

16.3. Fujifilm 78

16.4. Ethicon Endo-Surgery 78

16.5. Medtronic 78

16.6. Stryker 78

16.7. Smith & Nephew 78

16.8. Karl Storz 78

16.9. Hoya 78

16.10. Company 10 78

16.11. Company 11 78

16.12. Company 12 78

16.13. Company 13 78

16.14. Company 14 78

List of Figures

FIG NO. 1. South Africa GASTROINTESTINAL PRODUCTS Market Revenue, 2018 – 2032 (USD Million) 22

FIG NO. 2. Porter’s Five Forces Analysis for South Africa GASTROINTESTINAL PRODUCTS Market 29

FIG NO. 3. Value Chain Analysis for South Africa GASTROINTESTINAL PRODUCTS Market 30

FIG NO. 4. South Africa GASTROINTESTINAL PRODUCTS Market Import Volume/Revenue, By South Africa, 2018 – 2023 32

FIG NO. 5. South Africa GASTROINTESTINAL PRODUCTS Market Export Volume/Revenue, By South Africa, 2018 – 2023 33

FIG NO. 6. South Africa GASTROINTESTINAL PRODUCTS Market Demand Volume/Revenue, By South Africa, 2018 – 2023 34

FIG NO. 7. South Africa GASTROINTESTINAL PRODUCTS Market Supply Volume/Revenue, By South Africa, 2018 – 2023 35

FIG NO. 8. South Africa GASTROINTESTINAL PRODUCTS Market Production Volume/Revenue, By South Africa, 2018 – 2023 36

FIG NO. 9. South Africa GASTROINTESTINAL PRODUCTS Market Price, By Devices, 2018 – 2023 37

FIG NO. 10. Raw Materials Price Trend Analysis, 2018 – 2023 38

FIG NO. 11. Manufacturing Cost Analysis 39

FIG NO. 12. Manufacturing Process 39

FIG NO. 13. Company Share Analysis, 2023 40

FIG NO. 14. Company Share Analysis, 2023 41

FIG NO. 15. Company Share Analysis, 2023 41

FIG NO. 16. Company Share Analysis, 2023 42

FIG NO. 17. GASTROINTESTINAL PRODUCTS Market – Company Volume Market Share, 2023 43

FIG NO. 18. GASTROINTESTINAL PRODUCTS Market – Company Revenue Market Share, 2023 44

FIG NO. 19. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Devices, 2023 & 2032 50

FIG NO. 20. Market Attractiveness Analysis, By Devices 51

FIG NO. 21. Incremental Revenue Growth Opportunity by Devices, 2024 – 2032 51

FIG NO. 22. GASTROINTESTINAL PRODUCTS Market Revenue, By Devices, 2018, 2023, 2027 & 2032 52

FIG NO. 23. South Africa GASTROINTESTINAL PRODUCTS Market for Endoscopy Devices, Revenue (USD Million) 2018 – 2032 53

FIG NO. 24. South Africa GASTROINTESTINAL PRODUCTS Market for Ablation Devices, Revenue (USD Million) 2018 – 2032 54

FIG NO. 25. South Africa GASTROINTESTINAL PRODUCTS Market for Motility Testing Devices, Revenue (USD Million) 2018 – 2032 55

FIG NO. 26. South Africa GASTROINTESTINAL PRODUCTS Market for Biospy Devices, Revenue (USD Million) 2018 – 2032 56

FIG NO. 27. South Africa GASTROINTESTINAL PRODUCTS Market for Stenting Devices, Revenue (USD Million) 2018 – 2032 57

FIG NO. 28. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Indications, 2023 & 2032 59

FIG NO. 29. Market Attractiveness Analysis, By Indications 60

FIG NO. 30. Incremental Revenue Growth Opportunity by Indications, 2024 – 2032 60

FIG NO. 31. GASTROINTESTINAL PRODUCTS Market Revenue, By Indications, 2018, 2023, 2027 & 2032 61

FIG NO. 32. South Africa GASTROINTESTINAL PRODUCTS Market for Gastrointestinal Cancers, Revenue (USD Million) 2018 – 2032 62

FIG NO. 33. South Africa GASTROINTESTINAL PRODUCTS Market for Gastroesophageal Reflux Disease, Revenue (USD Million) 2018 – 2032 63

FIG NO. 34. South Africa GASTROINTESTINAL PRODUCTS Market for Irritable Bowl Syndrome, Revenue (USD Million) 2018 – 2032 64

FIG NO. 35. South Africa GASTROINTESTINAL PRODUCTS Market for Inflammatory Bowel Disease, Revenue (USD Million) 2018 – 2032 65

FIG NO. 36. South Africa GASTROINTESTINAL PRODUCTS Market for Other Disease, Revenue (USD Million) 2018 – 2032 66

FIG NO. 37. GASTROINTESTINAL PRODUCTS Market Revenue Share, By End-user, 2023 & 2032 68

FIG NO. 38. Market Attractiveness Analysis, By End-user 69

FIG NO. 39. Incremental Revenue Growth Opportunity by End-user, 2024 – 2032 69

FIG NO. 40. GASTROINTESTINAL PRODUCTS Market Revenue, By End-user, 2018, 2023, 2027 & 2032 70

FIG NO. 41. South Africa GASTROINTESTINAL PRODUCTS Market for Hospital, Revenue (USD Million) 2018 – 2032 71

FIG NO. 42. South Africa GASTROINTESTINAL PRODUCTS Market for Ambulatory Surgical Center & Independent Surgical Center, Revenue (USD Million) 2018 – 2032 72

FIG NO. 43. South Africa GASTROINTESTINAL PRODUCTS Market for Clinics, Revenue (USD Million) 2018 – 2032 73

FIG NO. 44. South Africa GASTROINTESTINAL PRODUCTS Market for Other End Users, Revenue (USD Million) 2018 – 2032 74

FIG NO. 45. South Africa GASTROINTESTINAL PRODUCTS Market for End-user 5, Revenue (USD Million) 2018 – 2032 75

FIG NO. 46. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Technology, 2023 & 2032 77

FIG NO. 47. Market Attractiveness Analysis, By Technology 78

FIG NO. 48. Incremental Revenue Growth Opportunity by Technology, 2024 – 2032 78

FIG NO. 49. GASTROINTESTINAL PRODUCTS Market Revenue, By Technology, 2018, 2023, 2027 & 2032 79

FIG NO. 50. South Africa GASTROINTESTINAL PRODUCTS Market for Technology 1, Revenue (USD Million) 2018 – 2032 80

FIG NO. 51. South Africa GASTROINTESTINAL PRODUCTS Market for Technology 2, Revenue (USD Million) 2018 – 2032 81

FIG NO. 52. South Africa GASTROINTESTINAL PRODUCTS Market for Technology 3, Revenue (USD Million) 2018 – 2032 82

FIG NO. 53. GASTROINTESTINAL PRODUCTS Market Revenue Share, By Distribution Channel, 2023 & 2032 84

FIG NO. 54. Market Attractiveness Analysis, By Distribution Channel 85

FIG NO. 55. Incremental Revenue Growth Opportunity by Distribution Channel, 2024 – 2032 85

FIG NO. 56. GASTROINTESTINAL PRODUCTS Market Revenue, By Distribution Channel, 2018, 2023, 2027 & 2032 86

FIG NO. 57. South Africa GASTROINTESTINAL PRODUCTS Market for Distribution Channel 1, Revenue (USD Million) 2018 – 2032 87

FIG NO. 58. South Africa GASTROINTESTINAL PRODUCTS Market for Distribution Channel 2, Revenue (USD Million) 2018 – 2032 88

FIG NO. 59. South Africa GASTROINTESTINAL PRODUCTS Market for Distribution Channel 3, Revenue (USD Million) 2018 – 2032 89

FIG NO. 60. South Africa GASTROINTESTINAL PRODUCTS Market for Distribution Channel 4, Revenue (USD Million) 2018 – 2032 90

FIG NO. 61. South Africa GASTROINTESTINAL PRODUCTS Market for Distribution Channel 5, Revenue (USD Million) 2018 – 2032 91

FIG NO. 62. Research Methodology – Detailed View 100

FIG NO. 63. Research Methodology 101

Frequently Asked Questions

What is the current size of the South Africa Gastrointestinal Products market?

The South Africa gastrointestinal products market was valued at USD 57.82 million in 2023 and is projected to grow to USD 76.74 million by 2032, with a compound annual growth rate (CAGR) of 3.13%.

What factors are driving the growth of the South Africa Gastrointestinal Products market?

The growth is driven by the increasing prevalence of gastrointestinal disorders such as IBS and GERD, growing consumer awareness about digestive health, the rising adoption of natural and herbal solutions, advancements in treatment options, and improved healthcare infrastructure. Additionally, the increasing use of over-the-counter (OTC) products and the role of telemedicine are further propelling market growth.

What are the key segments within the South Africa Gastrointestinal Products market?

The market is segmented as follows:
• By Devices: Endoscopy Devices, Ablation Devices, Motility Testing Devices, Biopsy Devices, and Stenting Devices.
• By Indications: Gastrointestinal Cancers, Gastroesophageal Reflux Disease (GERD), Irritable Bowel Syndrome (IBS), Inflammatory Bowel Disease (IBD), and Other Diseases.
• By End-User: Hospitals, Ambulatory Surgical Centers & Independent Surgical Centers, Clinics, and Other End Users.
• By Geography: Gauteng, Western Cape, KwaZulu-Natal, and Eastern Cape.

What are some challenges faced by the South Africa Gastrointestinal Products market?

Key challenges include regulatory and compliance issues, which create barriers for market entry and innovation, and pricing pressures due to intense competition and economic constraints. The high costs of advanced treatment options also limit accessibility for some consumers, particularly in rural areas with less developed healthcare infrastructure.

Who are the major players in the South Africa Gastrointestinal Products market?

Major players include Olympus, Boston Scientific, Fujifilm, Ethicon Endo-Surgery, Medtronic, Stryker, Smith & Nephew, Karl Storz, and Hoya. These companies focus on innovation, offering advanced diagnostic and therapeutic solutions, and expanding their product portfolios to address the growing demand for gastrointestinal treatments.

Purchase Options

Single User

$2699

Multi User

$3699

Custom Report

$5699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –